Clinical Trial Update: Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 3 study evaluating long-term safety and efficacy of pregabalin in patients with partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Seizure Disorder, Partial | Phase 3 | Status: COMPLETED